Day: May 3, 2021

Upcoming Slate of Original Content Includes New Sports Docu-series ‘Promiseland’ and ‘Vince Carter: Legacy’, Featuring Respectively Ja Morant and Vince Carter, and The Unscripted Show ‘Inside the Black Box’, Which Explores the Role Race Plays In The Entertainment Industry Publishing Megabrand ‘Chicken Soup for The Soul’ To Bring Its Original Mission Of “Changing the World One Story at The Time” To A New Streaming Network In The Fall COS COB, Conn., May 03, 2021 (GLOBE NEWSWIRE) — Crackle Plus, a Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE) company and one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, made multiple announcements today during its NewFronts presentation, including a diverse new slate of original and exclusive programming, and the launch of a new...

DENVER, May 03, 2021 (GLOBE NEWSWIRE) — NewAge, Inc., the Colorado-based organic and healthy products company intending to become the world’s leading social selling and distribution company, announced today the launch of Nutrifii Kids™ Chewable Multivitamin, a daily supplement for support of the healthy development and immune systems of children and adolescents. According to the World Health Organization (WHO), school-age children, adolescents and adults are eating too many sugary foods and drinks and refined grains, and not enough foods that promote health such as fruits, vegetables, and whole grains. About 30% of all school-age children do not eat any fruit daily, yet over 40% of children consume a soft drink every day. New analysis of over 23,000 consumer packaged food products shows 69% are of relatively poor nutrient quality. The...

SAINT PAUL, Minn., May 03, 2021 (GLOBE NEWSWIRE) — Image Sensing Systems, Inc. (Nasdaq: ISNS) today announced results for its quarter ended March 31, 2021. First Quarter 2021 Financial SummaryFirst quarter royalties were $1.8 million, a decrease of 14 percent from the same period in the prior year. First quarter product sales were $1.2 million, an increase of 11 percent from the same period in the prior year. Operating expenses totaled $1.9 million in the first quarter of 2021, a decrease of 34 percent from the prior year period. Capitalized software costs in the first quarter of 2021 were $123,000 compared to $22,000 in the prior year period. The Company recognized other income of $931,000 for the forgiveness of the Paycheck Protection Program loan and accrued interest during the first quarter. Net income for the first quarter...

Presentation will highlight efficacy and safety data from the DERMIS-1 and DERMIS-2 pivotal Phase 3 studies evaluating roflumilast cream (ARQ-151) as a potential topical once-daily treatment for chronic plaque psoriasis WESTLAKE VILLAGE, Calif., May 03, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, will present efficacy and safety data from the DERMIS-1 and DERMIS-2 pivotal Phase 3 studies evaluating roflumilast cream (ARQ-151) as a potential once-daily topical treatment for chronic plaque psoriasis at the European Academy of Dermatology and Venereology (EADV) Spring Symposium May 6 – May 7, 2021. “The EADV symposium...

Demodex blepharitis is a common ocular condition that may affect up to 25 million Americans Atlas study shows that Demodex blepharitis negatively impacts daily life for 80 percent of patients Tarsus also presents complete efficacy and safety data from Phase 2b Europa trial, positive trial results used as the basis for the Saturn-1 & 2 pivotal trials IRVINE, Calif., May 03, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced data from its Demodex blepharitis clinical program presented at the virtual Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting. Demodex blepharitis...

VANCOUVER, British Columbia, May 03, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) filed its financial results for the fourth quarter of 2020 and full year ended December 31, 2020, and the related Management’s Discussion and Analysis; details of which are available on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com https://sedar.com/GetFile.do?lang=EN&docClass=5&issuerNo=00029863&issuerType=03&projectNo=03213922&docId=4948333 Highlights year 2020:Revenue increased to CAD$9,126,082 for the year 2020 as compared to CAD$5,413,594 for the year 2019 and CAD$1,556,742 for the year 2018 representing a 486% increase over the last two years. Revenue increase is a result of (i) additional towers that...